Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immunodeficiencies (PID)”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Not applicableLooking for participantsNCT06565078
What this trial is testing

A Database Survey to Evaluate the Safety of Immune Globulin Subcutaneous (Human), 20% Solution in Participants with Primary Immunodeficiency

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 100
Large-scale testing (Phase 3)Study completedNCT01461018
What this trial is testing

Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)

Who this might be right for
Primary Immune Deficiency
CSL Behring 22
Large-scale testing (Phase 3)Looking for participantsNCT06076642
What this trial is testing

A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 39
Not applicableUnknownNCT03668288
What this trial is testing

Tolerance and Patients' Satisfaction With IGHy

Who this might be right for
Secondary or Primary Immunodeficiency
CHU de Reims 20
Large-scale testing (Phase 3)Study completedNCT04842643
What this trial is testing

An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease

Who this might be right for
Primary Immunodeficiency Disease
Takeda 12
Large-scale testing (Phase 3)Study completedNCT02327351
What this trial is testing

TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID

Who this might be right for
Primary Immune Deficiency DisorderHematopoietic Stem Cell Transplantation
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 98
Post-approval studies (Phase 4)Study completedNCT03033745
What this trial is testing

Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID)

Who this might be right for
Primary Immunodeficiency
CSL Behring 49
Large-scale testing (Phase 3)Study completedNCT00405184
What this trial is testing

Ig NextGen 10% in Patients With Primary Immune Deficiency (PID)

Who this might be right for
Primary Immune Deficiency (PID)
CSL Limited 19
Not applicableStudy completedNCT02593188
What this trial is testing

Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 264
Not applicableNot Yet RecruitingNCT07189013
What this trial is testing

Assessing Patient Preference for Infusion Systems

Who this might be right for
Primary Immunodeficiencies (PID)Secondary Immunodeficiencies (SID)
KORU Medical Systems, Inc. 52
Early research (Phase 1)Looking for participantsNCT04691622
What this trial is testing

Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts

Who this might be right for
Viral InfectionHematopoietic Stem Cell Transplantation (HSCT)Primary Immunodeficiency Disorders (PID)
Children's National Research Institute 48
Large-scale testing (Phase 3)Study completedNCT00391131
What this trial is testing

Subcutaneous Ig NextGen 16% in PID Patients

Who this might be right for
Primary Immunodeficiency (PID)
CSL Limited 35
Large-scale testing (Phase 3)Study completedNCT01581593
What this trial is testing

Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)

Who this might be right for
Primary ImmunodeficiencyAgammaglobulinemiaHypogammaglobulinemia+1 more
Kedrion S.p.A. 45
Large-scale testing (Phase 3)Study completedNCT03961009
What this trial is testing

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients

Who this might be right for
Primary Immunodeficiency Disease
Kedrion S.p.A. 47
Not applicableStudy completedNCT05621876
What this trial is testing

Evaluation of an IgG Deficiency Rapid Screening Test: A Performance Study With Primary Immunodeficiency (PID) Patients in Tunisia

Who this might be right for
Primary Immunodeficiency Diseases
PATH 50
Not applicableStudy completedNCT06150534
What this trial is testing

At-Home Subcutaneous Immunoglobulin Replacement Therapy Using Alexa Skill

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 22
Large-scale testing (Phase 3)Study completedNCT04346108
What this trial is testing

Immune Globulin Subcutaneous (Human), 20% Solution (IGSC, 20%) in Japanese Participants With Primary Immunodeficiency Diseases (PID)

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 17
Not applicableLooking for participantsNCT07261891
What this trial is testing

Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders

Who this might be right for
Primary Immunodeficiency Diseases (PID)
prof. dr. Rik Schrijvers 20
Testing effectiveness (Phase 2)Study completedNCT00782106
What this trial is testing

Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 11
Large-scale testing (Phase 3)Study completedNCT01199705
What this trial is testing

Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

Who this might be right for
Primary Immune Deficiency
CSL Behring 25
Load More Results